Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together

Tertiary lymphoid organs (TLOs) are frequently observed in tissues affected by non-resolving inflammation as a result of infection, autoimmunity, cancer and allograft rejection. These highly ordered structures resemble the cellular composition of lymphoid follicles typically associated with the sple...

Full description

Bibliographic Details
Main Authors: Gareth Wyn Jones, David G Hill, Simon Arnett Jones
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00401/full
_version_ 1818112573650763776
author Gareth Wyn Jones
David G Hill
Simon Arnett Jones
author_facet Gareth Wyn Jones
David G Hill
Simon Arnett Jones
author_sort Gareth Wyn Jones
collection DOAJ
description Tertiary lymphoid organs (TLOs) are frequently observed in tissues affected by non-resolving inflammation as a result of infection, autoimmunity, cancer and allograft rejection. These highly ordered structures resemble the cellular composition of lymphoid follicles typically associated with the spleen and lymph node compartments. Although TLOs within tissues show varying degrees of organisation, they frequently display evidence of segregated T and B cell zones, follicular dendritic cell networks, a supporting stromal reticulum and high endothelial venules. In this respect, they mimic the activities of germinal centres and contribute to the local control of adaptive immune responses. Studies in various disease settings have described how these structures contribute to either beneficial or deleterious outcomes. While the development and architectural organisation of TLOs within inflamed tissues requires homeostatic chemokines, lymphoid and inflammatory cytokines and adhesion molecules, our understanding of the cells responsible for triggering these events is still evolving. Over the past 10-15 years novel immune cell subsets have been discovered that have more recently been implicated in the control of TLO development and function. In this review we will discuss the contribution of these cell types and consider the potential to develop new therapeutic strategies that target TLOs.
first_indexed 2024-12-11T03:21:05Z
format Article
id doaj.art-eb45dbcacd4d44c799f359a7a68abc45
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T03:21:05Z
publishDate 2016-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-eb45dbcacd4d44c799f359a7a68abc452022-12-22T01:22:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-10-01710.3389/fimmu.2016.00401220463Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come TogetherGareth Wyn Jones0David G Hill1Simon Arnett Jones2School of Medicine, Cardiff UniversitySchool of Medicine, Cardiff UniversitySchool of Medicine, Cardiff UniversityTertiary lymphoid organs (TLOs) are frequently observed in tissues affected by non-resolving inflammation as a result of infection, autoimmunity, cancer and allograft rejection. These highly ordered structures resemble the cellular composition of lymphoid follicles typically associated with the spleen and lymph node compartments. Although TLOs within tissues show varying degrees of organisation, they frequently display evidence of segregated T and B cell zones, follicular dendritic cell networks, a supporting stromal reticulum and high endothelial venules. In this respect, they mimic the activities of germinal centres and contribute to the local control of adaptive immune responses. Studies in various disease settings have described how these structures contribute to either beneficial or deleterious outcomes. While the development and architectural organisation of TLOs within inflamed tissues requires homeostatic chemokines, lymphoid and inflammatory cytokines and adhesion molecules, our understanding of the cells responsible for triggering these events is still evolving. Over the past 10-15 years novel immune cell subsets have been discovered that have more recently been implicated in the control of TLO development and function. In this review we will discuss the contribution of these cell types and consider the potential to develop new therapeutic strategies that target TLOs.http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00401/fullAutoimmunityInfectionCancerRheumatoid arthritislymphoid neogenesisTertiary lymphoid organs
spellingShingle Gareth Wyn Jones
David G Hill
Simon Arnett Jones
Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together
Frontiers in Immunology
Autoimmunity
Infection
Cancer
Rheumatoid arthritis
lymphoid neogenesis
Tertiary lymphoid organs
title Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together
title_full Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together
title_fullStr Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together
title_full_unstemmed Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together
title_short Understanding Immune Cells in Tertiary Lymphoid Organ Development: It’s All Starting to Come Together
title_sort understanding immune cells in tertiary lymphoid organ development it s all starting to come together
topic Autoimmunity
Infection
Cancer
Rheumatoid arthritis
lymphoid neogenesis
Tertiary lymphoid organs
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00401/full
work_keys_str_mv AT garethwynjones understandingimmunecellsintertiarylymphoidorgandevelopmentitsallstartingtocometogether
AT davidghill understandingimmunecellsintertiarylymphoidorgandevelopmentitsallstartingtocometogether
AT simonarnettjones understandingimmunecellsintertiarylymphoidorgandevelopmentitsallstartingtocometogether